This activity is jointly provided by Global Education Group and PlatformQ Health Education, LLC, in collaboration with the National Organization for Rare Disorders, Inc (NORD).

ACKNOWLEDGEMENT

This activity is supported by an educational grant from Amicus Therapeutics Inc.

DATE OF RELEASE/EXPIRATION

This activity was released on October 26, 2022 and is valid until October 26, 2023. Requests for credit must be made no later than October 26, 2023.

TARGET AUDIENCE

The educational design of this activity addresses the needs of neurologists (adult and pediatric), internal medicine physicians, primary care physicians, pediatricians, pharmacists, neurology advanced practice providers and nurses, and other clinicians who care for patients with LOPD.

STATEMENT OF NEED/PROGRAM OVERVIEW

Patients with late‐onset Pompe disease (LOPD) often experience significant diagnostic delays and are susceptible to potential misdiagnoses. In addition, current treatments are associated with a number of limitations, leading to investigations of new agents that may offer greater safety, tolerability, and efficacy.

Join Dr. Loren Peña to review the symptoms of LOPD, patient factors that might influence care, and advances in the management of LOPD. Dr. Peña will discuss how to effectively incorporate new treatments, when available, into daily clinical practice and differentiate current and emerging agents to determine their appropriate place in the care of LOPD. Clinicians will be prepared to engage their patients in effective shared decision-marking to develop care plans that address the needs of their patients with LOPD.

EDUCATIONAL OBJECTIVES

After completing this activity, the participant should be better able to:

• Recognize signs and symptoms that may raise the index of suspicion for LOPD
• Identify strategies and emerging agents to address limitations of current treatment options for LOPD
• Assess the comparative safety, efficacy, and tolerability profiles and therapeutic potential of agents being investigated for the treatment of LOPD
• Discuss the importance of engaging patients with LOPD via shared decision‐making and how it could impact outcomes

PHYSICIAN ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and PlatformQ Health Education, LLC. Global is accredited by the ACCME to provide continuing medical education for physicians.

PHYSICIAN CREDIT DESIGNATION

Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point(s) in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

ESTIMATED TIME TO COMPLETE

This activity should take approximately 60 minutes to complete.

INSTRUCTIONS TO RECEIVE CREDIT

In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a score of 70% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FEE INFORMATION & REFUND/CANCELLATION POLICY

There is no fee for this educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:

Name of Faculty or Presenter	Reported Financial Relationship
Loren D.M. Peña, MD, PhD Associate Professor of Pediatrics Cincinnati Children’s Hospital	Nothing to disclose

The planners and managers have the following relevant financial relationships with ineligible companies:

Name of Planner or Manager	Reported Financial Relationship
Lindsay Borvansky	Nothing to disclose
Andrea Funk	Nothing to disclose
Liddy Knight	Nothing to disclose
Ashley Cann	Nothing to disclose
Lauren Sinclair	Nothing to disclose
Colleen Heffner	Nothing to disclose
Carole Drexel	Nothing to disclose
Alissa Yost	Nothing to disclose

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PlatformQ Health Education, LLC do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CONTACT INFORMATION

Accreditation Support:

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com

Technical Support:

For any technical issues or issues with your CME Certificate, please contact NeuroSeriesLive.com at 877-394-1306 or at Support@NeuroSeriesLive.com.